Versantis AG

Versantis develops a new generation of effective medicines and reliable diagnostics to revolutionize the care of patients with liver disease. Its lead candidate, VS-01, has the potential to fill the medical gap between preventive drugs and liver transplantations, and received Orphan Drug Designations from both the FDA and EMA. With a pipeline embracing a broad range of indications, Versantis aims to answer the unmet medical need of millions of people worldwide.

Versantis raised a CHF 4.4M series A in 2017 and has been rewarded with the most prestigious scientific and entrepreneurial prizes.

Offres d'emploi

Regulatory/Clinical development specialist

Versantis AGZürich ETH-Hönggerberg

15.01.2018Poste à res­pon­sa­bil­i­tés
Gefunden auf versantis.ch

Evaluations

Actuellement aucun évaluation
Aidez les autres candidats et soyez le premier à évaluer cette entreprise.

Emplacement

Versantis AG

Otto-Stern-Weg 7
8093 Zürich

http://www.versantis.ch/